InvestorsObserver
×
News Home

Will Eyepoint Pharmaceuticals Inc (EYPT) Beat the Rest of the Stocks in the Healthcare Sector?

Thursday, March 21, 2024 11:43 AM | InvestorsObserver Analysts

Mentioned in this article

Will Eyepoint Pharmaceuticals Inc (EYPT) Beat the Rest of the Stocks in the Healthcare Sector?

Eyepoint Pharmaceuticals Inc (EYPT) is near the top in its sector according to InvestorsObserver. EYPT gets an overall rating of 81. That means it scores higher than 81% of stocks. Eyepoint Pharmaceuticals Inc gets a 95 rank in the Healthcare sector. Healthcare is number 1 out of 11 sectors.

Overall Score - 81
EYPT has an Overall Score of 81. Find out what this means to you and get the rest of the rankings on EYPT!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 81 means the stock is more attractive than 81 percent of stocks. Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Eyepoint Pharmaceuticals Inc Stock Today?

Eyepoint Pharmaceuticals Inc (EYPT) stock has fallen -1.81% while the S&P 500 is up 0.63% as of 11:34 AM on Thursday, Mar 21. EYPT is lower by -$0.42 from the previous closing price of $23.35 on volume of 141,256 shares. Over the past year the S&P 500 has risen 33.54% while EYPT is up 859.41%. EYPT lost -$1.82 per share the over the last 12 months. Click Here to get the full Stock Report for Eyepoint Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App